Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial - Concepedia

Concepedia

Publication | Open Access

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial

DOI Full Paper Access

159

Citations

21

References

2021

Year

Shabir A. Madhi, Anthonet Koen, Alane Izu, Lee Fairlie, Clare Cutland, Vicky L. Baillie, Sherman D. Padayachee, Keertan Dheda, Shaun Barnabas, Qasim Bhorat,

References

	Year	Citations

Page 1